The Shepherd International Academy project takes off in Manglauru suburbs

Dubai, May 18: An Indian working in a mining company in the UAE has become the latest expatriate to have lost his job for hate-filled social media posts targeting Islam and Muslims.

Brajkishore Gupta was fired without notice for calling Indian Muslims 'coronavirus spreaders' and hailing the Delhi violence as 'divine justice' in his Facebook posts.

Gupta, who is from Chapra, Bihar, was employed by Stevin Rock, a mining company headquartered in Ras Al Khaimah city.

"This isolated incident involving a junior employee was investigated and dealt with immediately resulting in the termination without notice of this person's employment with Stevin Rock," said the company's business development and exploration manager Jean-Francois Milian.

"Our company policy supports the direction of the UAE government in promoting tolerance and equality and strongly renouncing racism and discrimination and we have sent communications to all of our employees irrespective of their religious or ethnic background reminding them that any such behaviour is unacceptable and will lead to immediate dismissal," Milian was quoted as saying in the report.

Three Indians based in the UAE were either fired or suspended from their jobs for "Islamophobic" posts on social media early this month.

On April 20, India's ambassador to the UAE Pavan Kapoor had warned Indian expatriates against such behaviour.

"India and UAE share the value of non-discrimination on any grounds. Discrimination is against our moral fabric and the Rule of law. Indian nationals in the UAE should always remember this," he said in a tweet.

Last month, Sharjah-based businessman Sohan Roy had to apologise for "unintentionally hurting religious sentiments" through his poem, which alluded to a Muslim religious group.

In March, chef Trilok Singh was fired from a restaurant in Dubai for an online threat against a student in Delhi over her views on the Citizenship Amendment Act.

Bengaluru, May 27: Former Karnataka chief minister and JD-S leader HD Kumaraswamy on Wednesday said that the state government should withdraw the decision to name the Yelahanka bridge after Hindutva ideologue Vinayak Damodar Savarkar.

"The state government's decision to name the Yelahanka bridge after Savarkar is a disgrace to those who have struggled for the country's prosperity. This doesn't give a good name to the state government," Kumaraswamy tweeted.

"There are many great people who worked for the development of the country before and after independence. Their names could have been used for this bridge. Do other states name their bridges after our leaders? On behalf of the people of the state, I urge the state government to take a step back from this decision," he added.

The newly built Yelahanka bridge was named after Savarkar last year in a BBMP council meeting. Later it was sent to state government for approval. Tomorrow, the bridge is likely to be inaugurated for public use.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.